MRD Rapid 500 Panel | NGS Minimal Residual Disease Monitoring | IGB
Overview:
IGB offers the Twist Bioscience MRD Rapid 500 Panel is a scalable target enrichment solution for monitoring minimal residual disease that leverages Twist’s siliconbased DNA synthesis platform to design and manufacture capture panels for personalized medicine. Twist’s proprietary design algorithms and a streamlined manufacturing pipeline enable design automation, synthesis, and rapid turnaround time of as few as 6 business days from the time of order. Cast a broader net to fully characterize adjuvant response at a genomic level with MRD panels ranging from 50 to 500 probes per panel and are compatible with Twist’s existing NGS library preparation and hybrid capture workflow.
Panel Performance:
MRD Brochure
Product Sheet
